Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Special report
: The Fierce 50 of 2024
Rydapt
Pharma
Daiichi scores FDA nod for leukemia med Vanflyta
Daiichi Sankyo scored a long-awaited U.S. approval for quizartinib, teeing up a showdown with drugs from Novartis and Astellas Pharma.
Fraiser Kansteiner
Jul 21, 2023 10:05am
Astellas’ Xospata wins AML approval, with Daiichi close behind
Nov 29, 2018 10:31am
NICE issues early 'no' on RoActemra, Rydapt
Dec 6, 2017 12:00pm
Novartis wins FDA nod for Rydapt, new targeted drug for AML
Apr 28, 2017 11:36am
